ANI Pharmaceuticals Inc (ANIP)
66.09
+0.47
(+0.72%)
USD |
NASDAQ |
Apr 23, 16:00
66.14
+0.05
(+0.08%)
After-Hours: 20:00
ANI Pharmaceuticals Cash from Operations (TTM): 118.96M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 118.96M |
| September 30, 2023 | 69.82M |
| June 30, 2023 | 41.27M |
| March 31, 2023 | 9.163M |
| December 31, 2022 | -31.20M |
| September 30, 2022 | -38.99M |
| June 30, 2022 | -48.01M |
| March 31, 2022 | -36.29M |
| December 31, 2021 | 3.322M |
| September 30, 2021 | 9.798M |
| June 30, 2021 | 13.59M |
| March 31, 2021 | 34.22M |
| December 31, 2020 | 15.27M |
| September 30, 2020 | 25.78M |
| June 30, 2020 | 49.19M |
| March 31, 2020 | 33.05M |
| December 31, 2019 | 45.63M |
| September 30, 2019 | 68.06M |
| June 30, 2019 | 54.59M |
| March 31, 2019 | 58.44M |
| December 31, 2018 | 67.07M |
| September 30, 2018 | 55.65M |
| June 30, 2018 | 64.41M |
| March 31, 2018 | 55.82M |
| December 31, 2017 | 39.42M |
| Date | Value |
|---|---|
| September 30, 2017 | 35.70M |
| June 30, 2017 | 19.70M |
| March 31, 2017 | 23.03M |
| December 31, 2016 | 27.47M |
| September 30, 2016 | 20.09M |
| June 30, 2016 | 29.24M |
| March 31, 2016 | 27.11M |
| December 31, 2015 | 17.26M |
| September 30, 2015 | 23.30M |
| June 30, 2015 | 17.23M |
| March 31, 2015 | 17.97M |
| December 31, 2014 | 22.03M |
| September 30, 2014 | 8.427M |
| June 30, 2014 | 2.637M |
| March 31, 2014 | 3.840M |
| December 31, 2013 | -5.484M |
| September 30, 2013 | -5.783M |
| June 30, 2013 | -11.53M |
| March 31, 2013 | -21.74M |
| December 31, 2012 | -25.28M |
| September 30, 2012 | -33.04M |
| June 30, 2012 | -38.24M |
| March 31, 2012 | -45.09M |
| December 31, 2011 | -47.87M |
| September 30, 2011 | -51.15M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-48.01M
Minimum
Jun 2022
118.96M
Maximum
Dec 2023
23.01M
Average
25.78M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 49.58M |
| ADMA Biologics Inc | 8.80M |
| Dentsply Sirona Inc | 377.00M |
| Allogene Therapeutics Inc | -237.73M |
| Vanda Pharmaceuticals Inc | 12.80M |